Chandeshwari S Chilampalli

Title: The Innovative Contributions of Chandeshwari S Chilampalli

Introduction

Chandeshwari S Chilampalli is a notable inventor based in the United States. She has made significant strides in the field of pharmaceutical formulations, particularly focusing on pain management and opioid dependence. Her work is characterized by a commitment to developing effective treatment options for patients in need.

Latest Patents

Chilampalli holds a patent for the Sublingual Buprenorphine Spray. This invention provides sublingual formulations containing buprenorphine, a pharmaceutically acceptable salt thereof, or a derivative thereof. Additionally, the invention includes formulations that combine buprenorphine with naloxone, which are also pharmaceutically acceptable salts or derivatives. The method outlined in her patent aims to treat pain or opioid dependence by administering these sublingual formulations to patients requiring such treatment.

Career Highlights

Chilampalli is currently associated with Benuvia Therapeutics LLC, where she continues to contribute to innovative pharmaceutical solutions. Her work at Benuvia Therapeutics reflects her dedication to improving patient outcomes through advanced drug formulations.

Collaborations

Chilampalli collaborates with talented professionals in her field, including Kiran P Amancha and Venkat R Goskonda. These partnerships enhance the research and development efforts at Benuvia Therapeutics, fostering an environment of innovation.

Conclusion

Chandeshwari S Chilampalli's contributions to the field of pharmaceuticals, particularly through her patent for the Sublingual Buprenorphine Spray, highlight her role as an influential inventor. Her work not only addresses critical health issues but also showcases the importance of innovation in the medical field.